◆ TICKERBASE · GLOBAL STOCK FINANCIAL DATA LIBRARY

iShares Neuroscience and Healthcare ETF (IBRN) ETF Overview

Name: iShares Neuroscience and Healthcare ETF (IBRN) price history and fund statistics
Creator: TickerBase
License: https://creativecommons.org/licenses/by/4.0/

Price history, fund statistics and profile — an exchange-traded fund.

Exchange-Traded Funds · Health · DATA UPDATED 2026-08-31

iShares Neuroscience and Healthcare ETF (IBRN) is an exchange-traded fund managed by iShares in the "Health" category. It manages roughly $5 million in assets.

The fund will invest at least 80% of its assets in the component securities of its index and in investments that have economic characteristics that are substantially identical to the component securities of its index and may invest up to 20% of its assets in certain futures, options and swap contracts, cash and cash equivalents as well as in securities not included in the index, but which BFA believes will help the fund track the index.

Interactive chart & fund stats →

IBRN Fund Statistics

Expense ratio	0.47%
Trailing yield	0.87%
Assets under management	$5 million
Fund category	Health
Fund family	iShares
Inception	2022-08-24

The live price chart, fund profile and news are in the interactive IBRN viewer.

Other Companies in Health

GDOC · Goldman Sachs Future Health Care Equity ETF — $19 million
MEDX · Horizon Kinetics Medical ETF — $17 million
BMED · iShares Health Innovation Active ETF — $11 million
JDOC · Jpmorgan Healthcare Leaders ETF — $9 million
THNR · Amplify Weight Loss Drug & Treatment ETF — $5 million
NVOH · Novo Nordisk A/S (B Shares) ADRhedged — $4 million
EKG · First Trust Nasdaq Lux Digital Health Solutions ETF — $4 million
MDEV · First Trust Indxx Global Medical Devices ETF — $3 million

← IBP All “I” companies IBRX →

About TickerBase · Data methodology & sources · Privacy · Terms

TickerBase is provided for educational and informational purposes only. It does not constitute financial, investment, tax, or legal advice, or a recommendation to buy, sell, or hold any security. No price targets are published; any per-share value shown in the valuation workbench is generated entirely from reader-supplied assumptions and is not the publisher's view of fair value. Past performance does not predict future results. Figures are approximate and drawn from public filings; one-time items are noted where identified. Do your own research and consult a licensed professional before making any investment decision. The author may or may not hold positions in the securities discussed.